VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Determining the prevalence of MGUS & deciphering the mechanisms of disease progression

Rafat Abonour, MD, Indiana University School of Medicine, Indianapolis, IN, emphasizes the importance of determining the true prevalence of monoclonal gammopathy of undetermined significance (MGUS) and better understanding the mechanisms that lead to the development of multiple myeloma, sharing insights from the iStopMM (NCT03327597) and PROMISE (NCT03689595) studies. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter